Home
About
FAQ
History (1)
Tracking the price of existing biologics when drugs enter the market.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
Tracking the price of existing biologics when drugs enter the market.
Stiff KM, Cline A, Feldman SR. Tracking the price of existing biologics when drugs enter the market. Expert Rev Pharmacoecon Outcomes Res. 2019 Aug; 19(4):375-377.
View in:
PubMed
subject areas
Biological Products
Drug Approval
Drug Costs
Humans
authors with profiles
Steven R. Feldman MD, PhD